Pmv Pharmaceuticalsinc Stock Piotroski F Score
| PMVP Stock | USD 1.62 0.01 0.62% |
Pmv | Piotroski F Score |
At this time, it appears that Pmv PharmaceuticalsI's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
| Current Return On Assets | Negative |
| Change in Return on Assets | Decreased |
| Cash Flow Return on Assets | Negative |
| Current Quality of Earnings (accrual) | Improving |
| Asset Turnover Growth | No Change |
| Current Ratio Change | Decrease |
| Long Term Debt Over Assets Change | N/A |
| Change In Outstending Shares | Decrease |
| Change in Gross Margin | No Change |
Pmv PharmaceuticalsI Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Pmv PharmaceuticalsI is to make sure Pmv is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Pmv PharmaceuticalsI's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Pmv PharmaceuticalsI's financial numbers are properly reported.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Current Liabilities | 9.2 M | 14 M |
|
| |||||
| Non Current Liabilities Total | 11.8 M | 12.4 M |
|
| |||||
| Total Assets | 254.1 M | 252.2 M |
|
| |||||
| Total Current Assets | 235.5 M | 207.4 M |
|
|
Pmv PharmaceuticalsInc F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Pmv PharmaceuticalsI's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Pmv PharmaceuticalsI in a much-optimized way.
| -0.86 | 0.29 | -0.46 | 0.69 | 0.74 | -0.18 | ||
| -0.86 | -0.29 | 0.68 | -0.7 | -0.74 | 0.27 | ||
| 0.29 | -0.29 | -0.83 | 0.85 | 0.8 | -0.94 | ||
| -0.46 | 0.68 | -0.83 | -0.91 | -0.89 | 0.85 | ||
| 0.69 | -0.7 | 0.85 | -0.91 | 1.0 | -0.83 | ||
| 0.74 | -0.74 | 0.8 | -0.89 | 1.0 | -0.79 | ||
| -0.18 | 0.27 | -0.94 | 0.85 | -0.83 | -0.79 |
Click cells to compare fundamentals
About Pmv PharmaceuticalsI Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value Per Share |
|
Pmv PharmaceuticalsI Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pmv PharmaceuticalsI from analyzing Pmv PharmaceuticalsI's financial statements. These drivers represent accounts that assess Pmv PharmaceuticalsI's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pmv PharmaceuticalsI's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.6B | 2.8B | 1.0B | 396.7M | 148.8M | 141.4M | |
| Enterprise Value | 1.7B | 2.4B | 881.4M | 302.4M | 123.6M | 117.4M |
About Pmv PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pmv PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pmv PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pmv PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pmv PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pmv PharmaceuticalsI's short interest history, or implied volatility extrapolated from Pmv PharmaceuticalsI options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pmv PharmaceuticalsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Pmv PharmaceuticalsI Altman Z Score, Pmv PharmaceuticalsI Correlation, Pmv PharmaceuticalsI Valuation, as well as analyze Pmv PharmaceuticalsI Alpha and Beta and Pmv PharmaceuticalsI Hype Analysis. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.